Bio Medica Laboratories SME IPO GMP Update Today: Key Price Insights Revealed!

The Bio Medica Laboratories SME IPO is set to open for subscription on May 21, 2026, and aims to raise approximately ₹52 crore. The price band for the offer is set between ₹132 and ₹139 per share, creating a market lot of 1,000 shares. As the listing date approaches, investors are keenly monitoring the subscription data and overall market conditions to gauge potential interest in the IPO.

In terms of grey market sentiment, the IPO’s Grey Market Premium (GMP) today is recorded at ₹2, suggesting a mild yet stable interest ahead of the listing. On May 22, the GMP reached a high of ₹4, while it recorded a low of ₹0 the day prior, reflecting some dynamics in investor sentiment as they adjust their expectations. Currently, there is no available Kostak rate, and the Subject to Sauda price remains unlisted, indicating the grey market is still stabilizing around this IPO.

The interest in the Bio Medica Laboratories IPO can be seen as a positive sign for Indian investors, highlighting a cautious optimism within the SME IPO segment. As investors keep an eye on the subscription levels and grey market trends, this IPO could serve as an important barometer for future offerings in the market. The indications from the grey market reflect a watchful sentiment, suggesting that while there is interest, potential investors should remain prudent and assess all available data before making investment decisions.

Source: The Economic Times

(Expert Note: This report was prepared by the Wealthova IPO team.)